Key Aspects of Medical Practice in Patients With Haemophilia A

Lund University

Overview

The KAPPa project has the aim to create an international database in which information about clinical features, therapeutic management, burden of illness and costs of severe and moderate haemophilia A patients from different countries and sites is collected. The aim of this project is to analyse the influence of such different characteristics on medical, psychosocial and economic outcomes in patients over the long-term.

1000 patients with hemophilia A will be enrolled using a webbased registry. Key quality factors that will be registered are : hemophilia joint Health score (HJHS), annual bleed rate, quality of Life (EQ5D), as well as dosing of replacement therapy.

Study Type

OBSERVATIONAL

Conditions

Joint Disease

Interventions

Factor VIII replacementBIOLOGICAL

Patients receive their usual treatment

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: or forms. * severe haemophilia A (factor VIII\<1%) * moderate (factor VIII\<5%) * signed informed consent Exclusion Criteria: * Not fullfilling inclusion criteria

Outcomes

Primary Outcomes

Outcome of factor replacement treatment

Joint disase according to HJHS. Quality of Life. Health economic evalaution.

Time frame: 3 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.